BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1653381)

  • 1. Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II.
    Yokota I; Takeda E; Ito M; Kobashi H; Saijo T; Kuroda Y
    J Inherit Metab Dis; 1991; 14(2):231-40. PubMed ID: 1653381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
    Griffin JE; Zerwekh JE
    J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents.
    Chen TL; Hirst MA; Cone CM; Hochberg Z; Tietze HU; Feldman D
    J Clin Endocrinol Metab; 1984 Sep; 59(3):383-8. PubMed ID: 6086691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
    Gamblin GT; Liberman UA; Eil C; Downs RW; DeGrange DA; Marx SJ
    J Clin Invest; 1985 Mar; 75(3):954-60. PubMed ID: 3872316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases.
    Mandla S; Jones G; Tenenhouse HS
    J Clin Endocrinol Metab; 1992 Apr; 74(4):814-20. PubMed ID: 1548347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
    Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
    J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25-Hydroxyvitamin D-24-hydroxylase in phytohemagglutinin-stimulated lymphocytes: intermediate bioresponse to 1,25-dihydroxyvitamin D3 of cells from parents of patients with vitamin D-dependent rickets type II.
    Takeda E; Yokota I; Ito M; Kobashi H; Saijo T; Kuroda Y
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1068-74. PubMed ID: 2156884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
    Zhu W; Malloy PJ; Delvin E; Chabot G; Feldman D
    J Bone Miner Res; 1998 Feb; 13(2):259-64. PubMed ID: 9495519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
    Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
    Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II.
    Malloy PJ; Hochberg Z; Pike JW; Feldman D
    J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
    J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3.
    Feldman D; Chen T; Cone C; Hirst M; Shani S; Benderli A; Hochberg Z
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1020-2. PubMed ID: 6288751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
    Roy S; Martel J; Tenenhouse HS
    J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study.
    Awumey EM; Mitra DA; Hollis BW; Kumar R; Bell NH
    J Clin Endocrinol Metab; 1998 Jan; 83(1):169-73. PubMed ID: 9435436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant form of the 1,25-dihydroxyvitamin D3 receptor with low apparent hormone affinity in cultured monkey kidney cells (LLC-MK2). A model for tissue resistance to vitamin D.
    Kelly MA; Marion SL; Donaldson CA; Pike JW; Haussler MR
    J Biol Chem; 1985 Feb; 260(3):1545-9. PubMed ID: 2981861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL; Hauschka PV; Cabrales S; Feldman D
    Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid.
    Hirst MA; Hochman HI; Feldman D
    J Clin Endocrinol Metab; 1985 Mar; 60(3):490-5. PubMed ID: 2982898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
    Chen TL; Hauschka PV; Feldman D
    Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations.
    Nguyen TM; Lieberherr M; Fritsch J; Guillozo H; Alvarez ML; Fitouri Z; Jehan F; Garabédian M
    J Biol Chem; 2004 Feb; 279(9):7591-7. PubMed ID: 14665637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.